ICD-10-CM Billable Code

C50.221

Malignant neoplasm of upper-inner quadrant of right male breast

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the upper-inner quadrant of the right male breast is a specific type of breast cancer that affects men. This condition involves the uncontrolled growth of cancer cells within the tissues of the upper-inner part of the right breast. Although breast cancer is more common among women, men can also develop this disease, making awareness and early detection essential for effective management.

Causes & Symptoms

Clinical Causes: Genetic factors, such as mutations in BRCA1 and BRCA2 genes Family history of breast cancer or other cancers Hormonal influences, notably increased levels of estrogen or androgens Radiation exposure to the chest area Lifestyle factors, including alcohol consumption, obesity, and lack of physical activity Previous radiation therapy to the chest Environmental exposures that may contribute to DNA damage

Key Symptoms: A lump or thickening in the upper-inner quadrant of the right breast Changes in the size, shape, or appearance of the right breast Skin changes over the affected area, such as redness, dimpling, or puckering Nipple changes, including inversion, discharge, or ulceration Persistent pain or discomfort in the breast or nipple area Swelling in the nearby lymph nodes, especially in the armpit

Diagnostic & Treatment

Diagnosis Path: Medical history assessment, focusing on risk factors and symptoms Physical examination of both breasts and regional lymph nodes Imaging studies, such as mammography or ultrasound, to identify suspicious masses Biopsy procedures, including core needle or surgical biopsy, to obtain tissue samples for histopathological analysis Additional imaging tests like MRI or CT scans to determine the spread of the cancer (staging) Laboratory tests to analyze tumor markers and assess overall health

Treatment Protocols: Surgery: removal of the tumor through procedures such as mastectomy or lumpectomy Radiation therapy: targeting cancerous tissues to eradicate remaining cancer cells after surgery Chemotherapy: using drugs to kill cancer cells, often administered before or after surgery Hormonal therapy: medications like tamoxifen that block hormone receptors if the tumor is hormone receptor-positive Targeted therapy: drugs designed to interfere with specific molecules involved in tumor growth Immunotherapy: treatments that help bolster the body's immune response against cancer cells

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.221 a billable ICD-10 code?
Yes, C50.221 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.221?
Clinical documentation must specify the nature of Malignant neoplasm of upper-inner quadrant of right male breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference